DE3786256D1 - Antifolat-mittel. - Google Patents

Antifolat-mittel.

Info

Publication number
DE3786256D1
DE3786256D1 DE8787907792T DE3786256T DE3786256D1 DE 3786256 D1 DE3786256 D1 DE 3786256D1 DE 8787907792 T DE8787907792 T DE 8787907792T DE 3786256 T DE3786256 T DE 3786256T DE 3786256 D1 DE3786256 D1 DE 3786256D1
Authority
DE
Germany
Prior art keywords
alkyl
agents
group
formula
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787907792T
Other languages
English (en)
Other versions
DE3786256T2 (de
Inventor
Malcolm Francis Graham Stevens
Roger John Griffin
Michelle Anne Nee Mee Robinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
British Technology Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868628731A external-priority patent/GB8628731D0/en
Priority claimed from GB878721283A external-priority patent/GB8721283D0/en
Priority claimed from GB878721284A external-priority patent/GB8721284D0/en
Application filed by British Technology Group Ltd filed Critical British Technology Group Ltd
Publication of DE3786256D1 publication Critical patent/DE3786256D1/de
Application granted granted Critical
Publication of DE3786256T2 publication Critical patent/DE3786256T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE87907792T 1986-12-02 1987-11-30 Antifolat-mittel. Expired - Fee Related DE3786256T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB868628731A GB8628731D0 (en) 1986-12-02 1986-12-02 Antifolate agents
GB878721283A GB8721283D0 (en) 1987-09-10 1987-09-10 Antifolate agents
GB878721284A GB8721284D0 (en) 1987-09-10 1987-09-10 Antifolate agents

Publications (2)

Publication Number Publication Date
DE3786256D1 true DE3786256D1 (de) 1993-07-22
DE3786256T2 DE3786256T2 (de) 1993-10-07

Family

ID=27263226

Family Applications (1)

Application Number Title Priority Date Filing Date
DE87907792T Expired - Fee Related DE3786256T2 (de) 1986-12-02 1987-11-30 Antifolat-mittel.

Country Status (7)

Country Link
US (1) US4992444A (de)
EP (1) EP0290558B1 (de)
JP (1) JP2704747B2 (de)
AT (1) ATE90673T1 (de)
DE (1) DE3786256T2 (de)
GB (1) GB2204867B (de)
WO (1) WO1988004293A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08504798A (ja) * 1992-12-18 1996-05-21 ザ ウエルカム ファウンデーション リミテッド 酵素阻害薬としての，ピリミジン，ピリジン，プテリジノンおよびインダゾール誘導体
GB9226377D0 (en) * 1992-12-18 1993-02-10 Babbedge Rachel C Pharmaceutical compositions
US5747476A (en) * 1996-07-17 1998-05-05 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoal myeloencephalitis
GB9700664D0 (en) * 1997-01-14 1997-03-05 British Tech Group Anti-cancer agents
US7371758B2 (en) * 2003-03-13 2008-05-13 National Science & Technology Development Agency Antimalarial pyrimidine derivatives and methods of making and using them
US20050171132A1 (en) * 2003-09-26 2005-08-04 Zhili Xin Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (GHS-R) antagonists
WO2014145386A2 (en) * 2013-03-15 2014-09-18 University Of Florida Research Foundation Incorporated Novel allosteric inhibitors of thymidylate synthase
US10835524B2 (en) 2015-06-24 2020-11-17 University Of Florida Research Foundation, Incorporated Compositions for the treatment of pancreatic cancer and uses thereof
WO2023081141A1 (en) * 2021-11-02 2023-05-11 University Of Florida Research Foundation, Incorporated Thymidylate synthase inhibitors and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2903850A1 (de) * 1979-02-01 1980-08-07 Bayer Ag 2-amino-8-cyclopropyl-5-oxo-5,8- dihydro-pyrido eckige klammer auf 2,3-d eckige klammer zu -pyrimidin-6-carnonsaeuren, verfahren zu ihrer herstellung sowie ihrer verwendung als antibakterielle mittel
GB8314643D0 (en) * 1983-05-26 1983-06-29 Wellcome Found Pyrimidine derivatives
GB8410636D0 (en) * 1984-04-26 1984-05-31 Stevens M F G Pharmaceutical substances/compositions

Also Published As

Publication number Publication date
GB8728018D0 (en) 1988-01-06
ATE90673T1 (de) 1993-07-15
JPH01501477A (ja) 1989-05-25
JP2704747B2 (ja) 1998-01-26
EP0290558A1 (de) 1988-11-17
WO1988004293A1 (en) 1988-06-16
GB2204867A (en) 1988-11-23
GB2204867B (en) 1991-05-29
EP0290558B1 (de) 1993-06-16
US4992444A (en) 1991-02-12
DE3786256T2 (de) 1993-10-07

Similar Documents

Publication Publication Date Title
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
MX173630B (es) Derivados de aminoacido, procedimiento para su preparacion y su preparacion y medicamento que los contiene
FI802404A (fi) Foerfarande foer framstaellning av terapeutiskt aktiva heterocykliska foereningar
ATE161836T1 (de) 4-substituierte-2-deoxy-2,3-didehydro alpha-d- neuraminsäure antivirale derivate
FI900085A (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(pyrimidin- ja kondensoitu pyrimidin-4-oni)etyyli-piperidiini- ja piperatsiinijohdannaisten valmistamiseksi
FI884375A (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(1-alkyyli-3-hydroksi-4-piperidinyyli)bentsamidien valmistamiseksi
NO921413D0 (no) Pyrazolopyridin-forbindelser og fremgangsmaate for fremstilling derav
DE3786256D1 (de) Antifolat-mittel.
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
CA2010639A1 (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2-thiones
DK454685A (da) Pyrazolo(3,4-b)-pyridinamider
ES2028838T3 (es) Procedimiento para la obtencion de nuevos derivados de 4,5-hidro-oxazoles.
DE3063525D1 (en) Process for the preparation of phosphono-hydroxy-acetic acid and salts thereof and autiviral compositions containing them
PT77666A (fr) Procede de preparation de nouveaux derives de la nitrosouree
ES2016305B3 (es) Compuestos de piperazina, procedimiento para prepararlos y composicion farmaceutica y su uso.
GB2152508A (en) Pyrimidine derivatives
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
ATE44875T1 (de) 4-amino-2-(imidazolidin-2-on-l-yl)-pyrimidin-5carbons|ure-(n-(3-trifluormethyl-phenyl)-amide) zur antithrombotischen prophylaxe und behandlung sowie ihre verwendung zur herstellung von antithrombotisch wirksamen arzneimitteln.
DK364386A (da) 1-alkyl-ergolinyl-thiourinstofderivater og fremgangsmaade til fremstilling deraf samt deres anvendelse
TH893EX (th) การเตรียมอนุพันธ์ของเบนซิมิดาโซลและสารผสมของสารเหล่านี้
NO823682L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridazinonimin-derivater.
TH5602A (th) สารประกอบทางเภสัชวิทยาชนิดใหม่
TH2131B (th) การเตรียมอนุพันธ์ของเบนซิมิดาโซลและสารผสมของสารเหล่านี้
PT89483A (pt) Processo para a preparacao de derivados da 2-amino acetamida
TH5602EX (th) สารประกอบทางเภสัชวิทยาชนิดใหม่

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee